Connect with us

Hi, what are you looking for?

Top Stories

Butterfly Network Announces $15M Midjourney Licensing Deal, Launches Compass AI to Boost Revenue

Butterfly Network secures a $15M licensing deal with Midjourney and launches Compass AI to enhance ultrasound efficiency and drive $135.9M revenue by 2028

On November 17, 2025, **Butterfly Network, Inc.** announced a significant five-year, exclusive co-development and licensing agreement with **Midjourney**. The deal, valued at **US$15 million** in upfront payments along with ongoing **US$10 million** annual license fees, milestone payments, and revenue sharing, grants Midjourney access to Butterfly’s **semiconductor-based ultrasound technology**. This partnership marks a pivotal move in the company’s strategy to bolster its digital health offerings and further its ambitions in the rapidly evolving healthcare technology landscape.

This licensing agreement comes on the heels of Butterfly Network’s recent launch of **Compass AI**, an innovative platform designed to enhance point-of-care ultrasound workflow efficiency through artificial intelligence. By improving efficiency and compliance in ultrasound procedures, Compass AI is expected to catalyze Butterfly’s technology commercialization efforts and expand its enterprise software capabilities. The development signals a blend of advanced imaging technology and AI, positioning Butterfly Network to capitalize on the growing demand for digital health solutions.

While the **US$15 million** upfront payment from Midjourney provides immediate revenue benefits, analysts emphasize that it does not address Butterfly’s most pressing challenge: the need to accelerate deals with large enterprises and medical schools. Investors focusing on Butterfly must evaluate the company’s ability to transition a substantial portion of medical imaging workflows onto its digital platforms, which remains a critical measure of success. Despite the promising partnership, the persistent risk of slow enterprise sales cycles poses a significant hurdle for the company moving forward.

Compass AI, particularly, might be the most relevant factor influencing the Midjourney deal. By showcasing robust, AI-enhanced workflow capabilities, the platform aims to attract more healthcare institutions and drive adoption of Butterfly’s technology. This could lead to increased software subscription revenues and improved documentation compliance at client sites, thus providing a potential buffer against the challenges associated with prolonged sales cycles.

Looking ahead, Butterfly Network projects revenues of **$135.9 million** and earnings of **$17.0 million** by **2028**. To achieve these ambitious targets, the company would need to demonstrate a **15.8%** annual revenue growth rate and a substantial earnings increase of **$79.8 million** from current losses of **$62.8 million**. Such forecasts invite scrutiny from investors, particularly in light of the industry’s volatile nature and the inherent risks of healthcare technology.

Market sentiment surrounding Butterfly Network remains mixed. According to estimates from the **Simply Wall St Community**, fair value estimates for the company’s stock range from **US$0.87** to **US$10.29** per share. This wide variance underscores the uncertainty regarding the company’s prospects, particularly its ability to accelerate enterprise deal closures. Investors must weigh these perspectives against their expectations for sales momentum and revenue growth as they consider the company’s future trajectory.

As the healthcare landscape continues to evolve, Butterfly Network’s strategic partnerships and product innovations, including the Midjourney agreement and the introduction of Compass AI, will be instrumental in shaping its narrative. The company’s approach reflects a broader trend toward digitization and the integration of advanced technologies in healthcare, an area witnessing significant investment and growth. However, the journey to profitability is fraught with challenges, and the effectiveness of its strategies will be critical in determining the success of Butterfly Network in a competitive market.

In conclusion, while Butterfly Network’s recent agreements and technological advancements present a promising outlook, the company must navigate existing risks and capitalize on emerging opportunities to fulfill its ambitious revenue and earnings targets. As the healthcare sector increasingly embraces digital solutions, the future of Butterfly Network will likely hinge on its ability to innovate and adapt in this dynamic environment.

See also
Staff
Written By

The AiPressa Staff team brings you comprehensive coverage of the artificial intelligence industry, including breaking news, research developments, business trends, and policy updates. Our mission is to keep you informed about the rapidly evolving world of AI technology.

You May Also Like

Top Stories

Cohu, Inc. posts Q4 2025 sales rise to $122.23M but widens annual loss to $74.27M, highlighting risks amid semiconductor market volatility.

Top Stories

Alibaba and ByteDance unveil Qwen-Image-2.0 and Seedream 5.0, revolutionizing AI image generation with enhanced controllability and adaptability ahead of the Spring Festival.

Top Stories

Litigation over AI training datasets escalates as courts weigh fair use, with Thomson Reuters winning a pivotal ruling against Ross Intelligence on market impact.

Top Stories

Leonardo.ai, with over 55 million creators, emerges as a leading AI image generator in 2026, offering unique controls that cater to both indie developers...

AI Business

Algorhythm Holdings' SemiCab AI enables freight operators to increase volumes by 400% and achieve 4x productivity without adding staff.

Top Stories

BeeGraphix's Julia Saxon leverages AI tools like ChatGPT and Midjourney to create a dynamic branded merchandise collection that embodies collaboration, revolutionizing design efficiency.

AI Business

Synthpop secures $15M in Series A funding to enhance its AI platform, automating 80% of healthcare workflows and reducing processing times from 40 minutes...

Top Stories

Astera Labs shares surged 18.9% to $170 as analysts project a $202 target, driven by soaring demand for AI connectivity solutions.

© 2025 AIPressa · Part of Buzzora Media · All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site. Some images used on this website are generated with artificial intelligence and are illustrative in nature. They may not accurately represent the products, people, or events described in the articles.